|
1
|
The Internet as recruitment tool for HIV studies: viable strategy for reaching at-risk Hispanic MSM in Miami?
|
AIDS Care
|
2004
|
1.67
|
|
2
|
Differential secretion of tumor necrosis factor-alpha and granulocyte/macrophage colony-stimulating factors but not interferon-gamma from CD4+ compared to CD8+ human T cell clones.
|
Eur J Immunol
|
1989
|
1.08
|
|
3
|
Human T-cell clones in long-term culture as a model of immunosenescence.
|
Immunol Rev
|
1997
|
1.01
|
|
4
|
IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-alpha.
|
J Immunol
|
1989
|
0.96
|
|
5
|
Immunosenescence, suppression and tumour progression.
|
Cancer Immunol Immunother
|
2005
|
0.93
|
|
6
|
Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity.
|
J Immunol
|
1982
|
0.91
|
|
7
|
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells.
|
Int J Immunopharmacol
|
1991
|
0.88
|
|
8
|
Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?
|
Mech Ageing Dev
|
1995
|
0.86
|
|
9
|
Alloproliferative human T cell clones primed and cultured in vitro lose proliferative and gain suppressive activity with age.
|
Hum Immunol
|
1984
|
0.84
|
|
10
|
Retention of specific proliferative capacity of cloned human T cells alloactivated against HLA-D alleles.
|
Immunogenetics
|
1980
|
0.84
|
|
11
|
Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones.
|
Exp Gerontol
|
1998
|
0.84
|
|
12
|
HLA-DP in rheumatoid arthritis.
|
Tissue Antigens
|
1988
|
0.83
|
|
13
|
Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
|
Immunology
|
1981
|
0.83
|
|
14
|
Division of human helper T cells into two sets on the basis of the induction of anti-tumor cytotoxicity by phorbol ester and calcium ionophore.
|
Eur J Immunol
|
1988
|
0.82
|
|
15
|
Dissection of suppressor cell generation in vitro.
|
Hum Immunol
|
1986
|
0.82
|
|
16
|
Cytokine regulation of the balance between alloindifferent and allospecific suppressor induction in mixed lymphocyte cultures.
|
Transplantation
|
1990
|
0.81
|
|
17
|
Cloning of functional human T lymphocytes by limiting dilution: impact of filler cells and interleukin 2 sources on cloning efficiencies.
|
Scand J Immunol
|
1981
|
0.80
|
|
18
|
Homogeneity of the HLA-linked SB2 and SB3 specificities demonstrated by cloned alloreactive T cells.
|
Immunogenetics
|
1983
|
0.79
|
|
19
|
Prevention of human helper T-cell clone activation by cyclosporin A also blocks secretion of granulocyte/macrophage colony stimulating activity.
|
Immunopharmacology
|
1989
|
0.79
|
|
20
|
Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell death.
|
Cytokine
|
1996
|
0.79
|
|
21
|
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha.
|
Leuk Lymphoma
|
1995
|
0.79
|
|
22
|
Induction of hyporesponsiveness in human lymphocytes-T despite their expression of both the co-receptor CD28 and its ligand B7.
|
Cell Immunol
|
1993
|
0.78
|
|
23
|
Cytokine modulation of TH1/TH2 phenotype differentiation in directly alloresponsive CD4+ human T cells.
|
Transplantation
|
1996
|
0.78
|
|
24
|
Cyclosporin A blocks the generation of alloindifferent but not of allospecific suppressive cells.
|
Immunol Lett
|
1988
|
0.78
|
|
25
|
Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro.
|
Cancer Immunol Immunother
|
1996
|
0.78
|
|
26
|
Extrathymic T cell differentiation in vitro from human CD34+ stem cells.
|
J Leukoc Biol
|
1998
|
0.78
|
|
27
|
In vitro senescence models for human T lymphocytes.
|
Vaccine
|
2000
|
0.77
|
|
28
|
Regulation of allospecific suppressive cell generation in vitro.
|
Immunol Lett
|
1988
|
0.77
|
|
29
|
Human T cell clones with gamma/delta and alpha/beta receptors are differently stimulated by monoclonal antibodies to CD2.
|
Cell Immunol
|
1990
|
0.76
|
|
30
|
IFN-alpha regulates IL 10 production by CML cells in vitro.
|
Cancer Immunol Immunother
|
1999
|
0.75
|
|
31
|
Relationship between donor alloreactivity and acute GVHD in CML patients transplanted in the first chronic phase with HLA identical sibling marrow.
|
Bone Marrow Transplant
|
1993
|
0.75
|
|
32
|
Finite lifespans of T cell clones derived from CD34+ human haematopoietic stem cells in vitro.
|
Exp Gerontol
|
1999
|
0.75
|
|
33
|
Interleukin 10 is a human T cell growth factor in vitro.
|
Cytokine
|
1995
|
0.75
|
|
34
|
[On the use of chrome-gelatin and formalin-gelatin as an adhesive for tissue sections intended for treatment with performic acid (author's transl)].
|
Histochemistry
|
1974
|
0.75
|
|
35
|
Age-related loss of function of alloactivated interleukin 2-propagated human primed lymphocyte typing clones.
|
Scand J Immunol
|
1983
|
0.75
|
|
36
|
Evolution of a CD3+CD4+ alpha/beta T-cell receptor+ mature T-cell clone from CD3-CD7+ sorted human bone marrow cells.
|
Dev Immunol
|
1993
|
0.75
|
|
37
|
Restimulation properties of cloned alloactivated lymphocytes: detection of a novel type of HLA-D/DR region determinant and allelic subtypes for HLA-Dw3 using cloned reagents.
|
Hum Immunol
|
1981
|
0.75
|
|
38
|
Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: effects on cytokine production and suppressor cell status.
|
Biotherapy
|
1991
|
0.75
|
|
39
|
Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.
|
Cancer Immunol Immunother
|
1989
|
0.75
|
|
40
|
Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).
|
Cancer Immunol Immunother
|
1989
|
0.75
|
|
41
|
Extrathymic development and function of human T-lymphocytes from bone marrow cells in vitro.
|
Cell Immunol
|
1994
|
0.75
|
|
42
|
Acquisition of suppressive and natural killer-like activities associated with loss of alloreactivity in human "helper" T-lymphocyte clones.
|
Curr Top Microbiol Immunol
|
1986
|
0.75
|
|
43
|
HLA-DP matching in allogeneic bone marrow transplantation.
|
Transplant Proc
|
1987
|
0.75
|
|
44
|
Human gamma delta T cells are resistant to induction of anergy but not to induction of cell death in vitro.
|
Cell Immunol
|
1995
|
0.75
|
|
45
|
Discrete PLT clones detecting HLA-D and new HLA-non-D encoded cell surface determinants.
|
Tissue Antigens
|
1982
|
0.75
|
|
46
|
Activity of liposomal interleukin-2 in vitro.
|
Mol Biother
|
1992
|
0.75
|
|
47
|
Relative cloning efficiencies and long-term propagation capacity for T cell clones of highly purified natural interleukin 2 compared to recombinant interleukin 2 in man.
|
Immunobiology
|
1987
|
0.75
|
|
48
|
Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon alpha.
|
Cancer Immunol Immunother
|
1991
|
0.75
|
|
49
|
Involvement of "accessory" and antigen receptor molecules in human helper T cell clone activation studied by monoclonal antibody inhibition.
|
Hum Immunol
|
1989
|
0.75
|
|
50
|
The new HLA-DRw6- and 8- associated HLA-Dw HAG specificity defined by homozygous typing cell 9W 1802. Analysis with primed lymphocyte typing clones.
|
Tissue Antigens
|
1984
|
0.75
|
|
51
|
Frequencies of HLA-DP alleles in the four major types of leukaemia.
|
Tissue Antigens
|
1989
|
0.75
|